generic glp-1 2024 FDA Approves First Weight Loss Drug Teva Announces Launch of Generic
Description
doi: 10.1016/j.jacc.2023.09.811
Every compounded GLP-1 that is replaced by a generic/branded product is a win for drug safety
One year of sitagliprin treatment does not result in exocrine pancreatic pathology in mice (Abstract)
Thats dangerously misleading
